EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the diagnostic and prognostic role of TSPAN32 in B-cell acute lymphoblastic leukemia

Grazia Scuderi, Loredana Cocomero, Eugenio Cavalli, Ferdinando Nicoletti, Paolo Fagone

Immunology Letters · 2026

DOI: 10.1016/j.imlet.2026.107151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2026. Verfasst von Grazia Scuderi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia, 97-95123-Catania-Italy. Hauptthemen laut MEDLINE: Tetraspanins, Biomarkers, Tumor, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematologic malignancy characterized by the uncontrolled proliferation of immature B-cell precursors. Despite therapeutic advances, outcomes remain poor in adults and relapsed patients, underscoring the need for novel targets. TSPAN32, a tetraspanin family member, is primarily expressed in hematopoietic tissues and implicated in immune regulation. In this study, we have evaluated the TSPAN32 expression across various B-ALL subtypes and correlated it with clinical data. TSPAN32 expression was significantly reduced in all subtypes compared to healthy bone marrow. Expression was relatively uniform within the B-ALL population, unaffected by differentiation stage. A significant negative correlation between TSPAN32 expression and blast percentage was also observed. Survival analysis revealed that lower TSPAN32 expression correlated with poorer overall survival. Gene expression analysis in sample diverging for the expression of TSPAN32 identified key pathways, including immune modulation and ECM processes, associated to TSPAN32 expression. In conclusion, TSPAN32 emerges as a molecule involved in the biology of B-ALL. Its prognostic value, consistent expression across age groups, and involvement in key signaling pathways highlight its potential as a biomarker for B-ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TetraspaninsBiomarkers, TumorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansPrognosisFemaleGene Expression Regulation, LeukemicMaleAdultGene Expression ProfilingSignal TransductionAdolescentChild

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaB-ALLTSPAN32Tetraspanins

Substanzen

TetraspaninsBiomarkers, TumorTSPAN32 protein, human

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia, 97-95123-Catania-Italy.
  • Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia, 97-95123-Catania-Italy. Electronic address: paolo.fagone@unict.it.

Zitieren

APA

Scuderi, G., Cocomero, L., Cavalli, E., Nicoletti, F., & Fagone, P. (2026). Evaluation of the diagnostic and prognostic role of TSPAN32 in B-cell acute lymphoblastic leukemia. Immunology Letters. https://doi.org/10.1016/j.imlet.2026.107151

Vancouver

Scuderi G, Cocomero L, Cavalli E, Nicoletti F, Fagone P. Evaluation of the diagnostic and prognostic role of TSPAN32 in B-cell acute lymphoblastic leukemia. Immunology Letters. 2026. doi:10.1016/j.imlet.2026.107151

BibTeX
@article{Scuderi2026,
  author = {Scuderi, Grazia and Cocomero, Loredana and Cavalli, Eugenio and Nicoletti, Ferdinando and Fagone, Paolo},
  title = {Evaluation of the diagnostic and prognostic role of TSPAN32 in B-cell acute lymphoblastic leukemia},
  journal = {Immunology Letters},
  year = {2026},
  doi = {10.1016/j.imlet.2026.107151}
}
Kostenlos starten →